
The Biotech IPO Drought May Be Ending: What LB Pharma’s $285M Raise Tells Us
After more than half a year without a sizable biotech IPO, LB Pharmaceuticals just raised $285 million in an upsized Nasdaq offering. For an industry
Coverage of early-stage science, platform technologies, R&D innovation, and emerging companies shaping the future of medicine. From discovery breakthroughs to financing rounds and pipeline progress, this section tracks the momentum driving the biotech ecosystem.

After more than half a year without a sizable biotech IPO, LB Pharmaceuticals just raised $285 million in an upsized Nasdaq offering. For an industry

After months of biotech companies avoiding public markets like the plague, LB Pharmaceuticals just broke the drought with a $285 million initial public offering that

August 2025 will be remembered as a watershed moment for the biotechnology industry, with over 20 companies announcing significant layoffs as the sector undergoes its

Taiwan-based biotech announces co-marketing agreement to push high-resolution subcellular mapping into new research frontiers Taiwan’s Syncell announced a strategic co-marketing agreement with Thermo Fisher Scientific

4,000-patient real-world study validates optimal ADC sequencing, driving strong investor confidence in precision oncology platform Caris Life Sciences shares surged following publication of breakthrough results

Strategic deal creates diversified specialty company with strong acute care presence and immediate revenue diversification CorMedix Inc. announced the completion of its $300 million acquisition

Sector evolution marked by breakthrough approvals, billion-dollar transactions, and emerging health challenges Recent global biotech developments showcase the sector’s dynamic nature, with breakthrough drug approvals,

Flow cytometry leader schedules presentations at three major healthcare investment conferences Cytek Biosciences announced its participation in three prominent investor conferences: the UBS Precision Medicine

Sector-wide fundraising activity reflects continued capital needs across biotech industry August 12 marked a particularly active day for biotech fundraising, with companies including 180 Life

Indian pharmaceutical company achieves peak performance amid ongoing financial pressures Windlas Biotech reported record Q2 net sales of approximately ₹210 crore (~$25 million USD) and